文献速递前列腺癌

保留Retzius间隙前列腺切除术对有症状淋巴囊肿发生率的影响

Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates.
PubMed 文献 · Urology · 2020-12-15

单中心回顾性研究比较保留Retzius间隙与标准机器人辅助前列腺切除术,共81例(保留Retzius间隙50例,标准31例)。有症状淋巴囊肿全部发生于保留Retzius间隙组(18%,平均术后34天),该术式是淋巴囊肿发生的显著预测因素(OR 23.77,95%CI 2-3725),多数需介入引流和静脉抗生素治疗。

要点

  • 保留Retzius间隙前列腺切除术后有症状淋巴囊肿发生率为18%,均见于该组。
  • 保留Retzius间隙术式是淋巴囊肿发生的显著预测因素,OR 23.77(95%CI 2-3725)。
  • 有症状淋巴囊肿平均发生于术后34天,多数需介入引流和静脉抗生素治疗。

核心结论

  • 保留Retzius间隙前列腺切除术是有症状淋巴囊肿的显著预测因素。
  • 有症状淋巴囊肿全部发生于保留Retzius间隙组,发生率为18%。

研究设计与样本

  • 单中心回顾性研究,回顾2019年9月18日至2020年7月15日由2名外科医生(1名使用SP,另1名使用Xi)实施的机器人辅助腹腔镜前列腺切除术。
  • 共纳入81例前列腺切除术,其中保留Retzius间隙50例,标准术式31例。

主要发现

  • 两组在年龄、BMI、分级分组、神经保留和T分期方面相似。
  • 保留Retzius间隙组淋巴结检出数更高,且更常使用Xi多孔系统。
  • 有症状淋巴囊肿全部发生于保留Retzius间隙组,发生率为18%,平均术后34天。
  • 保留Retzius间隙术式预测淋巴囊肿发生的比值比为23.77(95%CI 2-3725)。

关键数值与推荐

  • 有症状淋巴囊肿定义为患者因淋巴囊肿相关症状重返医院,并经腹部CT扫描确认。
  • 多数有症状淋巴囊肿需介入放射学引流和静脉抗生素治疗。

临床怎么用

  • 对于接受保留Retzius间隙前列腺切除术的患者,术后应警惕有症状淋巴囊肿的发生。
  • 出现相关症状时应行腹部CT确认,并准备介入引流和静脉抗生素治疗。

局限性

  • 回顾性单中心设计,样本量较小(共81例)。
  • 两组术式在淋巴结检出数和机器人系统使用上存在差异,可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare symptomatic lymphocele rates between standard and Retzius sparing prostatectomy approaches. METHODS: From September 18, 2019 to July 15, 2020, robot assisted laparoscopic prostatectomies by 2 surgeons (1 using SP and other Xi) at a single institution were retrospectively reviewed. Symptomatic lymphoceles were diagnosed after the patient represented to the hospital with symptoms attributable to lymphocele and confirmed by abdominal CT scan. Statistical analysis was performed using R Studio (1.2). RESULTS: There were 81 prostatectomies performed during the study period. Of these, 50 were Retzius sparing and 31 were standard approach. The 2 groups were similar in age, BMI, grade group, nerves spared, and T stage. Retzius sparing prostatectomies had higher lymph node yield and were more often performed with Xi multiport. Symptomatic lymphoceles were entirely present in the Retzius sparing group, occurring in 18% of cases at a mean time of 34 days after surgery. Retzius sparing approach was a significant predictor of lymphocele occurrence with an odds ratio of 23.77 (95% CI, 2-3725). CONCLUSION: Retzius sparing prostatectomy was a significant predictor of symptomatic lymphoceles. Most of these cases required IR drainage and IV antibiotics as treatment. This is likely due to impairment of lymph reabsorption as the peritoneal lining remains approximated during Retzius sparing prostatectomy.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Wong D, Rincon J, Henning G, et al. Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates. Urology. 2020. PMID: 33279613. doi:10.1016/j.urology.2020.11.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。